James Powers, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 60 High St., West Carthage, NY 13619 Phone: 315-493-6668 |
News Archive
Researchers at the University of Pittsburgh School of Medicine and Arts & Sciences have designed a more effective version of an FDA-approved epilepsy drug with the potential for fewer side effects, according to a study published on March 22 in Molecular Pharmacology. The experimental agent also could prove to be a treatment for tinnitus and other disorders caused by volatile neural signaling.
The cardiac rehabilitation program at Bayshore Community Hospital is pleased to announced that it has received certification from the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) for its strict standards of practice.
RL Solutions, creators of innovative and easy-to-use healthcare quality and safety software, announced today the general availability of its new incident and patient feedback reporting app, RL6:Mobile.
Aileron Therapeutics, Inc. today announced the completion of the first-in-human study of its lead Stapled Peptide drug, ALRN-5281, a proprietary, long-acting growth-hormone-releasing hormone (GHRH) agonist for treating orphan endocrine disorders, including adult growth hormone (GH) deficiency and human immunodeficiency virus (HIV) lipodystrophy, as well as broader patient populations involving a wide variety of metabolic/endocrine diseases.
› Verified 1 days ago